Aquatic Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,943
Closed -$259K 1702
2025
Q4
$259K Sell
6,943
-7,842
-53% -$319K 0.01% 927
2025
Q3
$598K Buy
14,785
+6,983
+90% +$231K 0.01% 826
2025
Q2
$199K Buy
7,802
+2,996
+62% +$65.3K ﹤0.01% 1017
2025
Q1
$103K Buy
4,806
+1,501
+45% +$33.5K ﹤0.01% 1061
2024
Q4
$69.4K Buy
+3,305
New +$76.5K ﹤0.01% 1125
2024
Q2
Sell
-1,500
Closed -$19.4K 1501
2024
Q1
$19.4K Sell
1,500
-2,300
-61% -$27.6K ﹤0.01% 1103
2023
Q4
$44K Buy
3,800
+2,200
+138% +$24.8K ﹤0.01% 1136
2023
Q3
$20K Buy
+1,600
New +$22.7K ﹤0.01% 1074
2022
Q1
Sell
-100
Closed -$2K 1404
2021
Q4
$2K Buy
+100
New +$2.13K ﹤0.01% 1049

Other funds holding PAHC

Aquatic Capital Management's PAHC Position: Q1 2026 in Review

Aquatic Capital Management sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 6,943 shares — an estimated $259K sold.

Aquatic Capital Management first reported a position in PAHC in Q4 2021 and held it in 9 quarters. The position peaked at $598K in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Aquatic Capital Management reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 6,943 Phibro Animal Health shares in Q1 2026, an estimated $259K.
  • Aquatic Capital Management first reported a position in Phibro Animal Health in Q4 2021 and held it in 9 quarters.
  • Aquatic Capital Management's Phibro Animal Health position peaked at $598K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.